17O was introduced into the respective alpha- and gamma-COOH groups of Boc-Gly and Boc-Glu by saponification of the corresponding O-methyl esters with 1N NaOH in H2 17O. Other 17O enriched Boc-amino acids were prepared by acid catalyzed exchange into the amino acid alpha-COOH group followed by t-butyloxycarbonylation with t-butyl S-4, 6-dimethylpyrimidin-2-ylthio carbonate. Final enrichment, by approximately three orders of magnitude over natural abundance, was 60-100% of the possible maximum. The synthesis of [17O]-Gly-Ala, [17O]-Gly-Leu and [17O]-Gly-Glu by DCC/HBT mediated coupling of Boc-Gly-[17O]-alpha-COOH with amino acid-O-t-butyl esters followed by deprotection with HCl/EtOAc proceeded without undue loss of the isotope. Boc-[17O]-Pro-Leu-Gly-NH2 was prepared by a similar procedure. [Tyr2-17O]-, [Pro7-17O]- and [Gly4-17O]-oxytocin were synthesized using solid phase support. 17O-chemical shifts of synthetic intermediates and of the final products were as expected for each functional group. Linewidth data correlate with the molecular weights of the compounds prepared.
No takes yet. Share an insight, caveat, or question.
Steinschneider et al. (1981) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: